Regen BioPharma, Inc. to Present at the Emerging Growth Conference
Regen BioPharma, Inc. is inviting both individual and institutional investors, as well as advisors and analysts, to join them for an interactive presentation at the upcoming Emerging Growth Conference.
Engagement Opportunities Await
On the virtual stage, Regen BioPharma, Inc. (OTC PINK: RGBP) will showcase its promising biotechnology projects. The company is well-regarded for its diverse pipeline, which includes cell therapies, RNA vaccines, RNA and DNA therapeutics, and small molecule drugs. This highly anticipated event is set for September 25.
Connect with Dr. David Koos
This engaging online event provides shareholders and interested investors the chance to interact directly with the company’s CEO, Dr. David Koos. Attendees will be encouraged to ask questions during the presentation, and the team will work to answer them promptly.
Updates on Goals and Progress
Dr. David Koos, CEO and Chairman, shared, "We intend to use this time to update our shareholders on our fiscal and scientific goals for the coming year, provide insights into our current programs, and discuss timelines for the anticipated HemaXellerate clinical phase I." This personal touch demonstrates the company's commitment to transparency and open communication.
Event Schedule
Mark your calendar: the Regen BioPharma presentation is scheduled for 4:00 PM to 4:10 PM Eastern Time on the day of the event. If you’d like to attend, be sure to register in advance to catch all the important updates.
Access to Archived Webcast
If you can’t attend live, don’t worry—an archived version of the presentation will be available on EmergingGrowth.com, so everyone can stay informed.
What is the Emerging Growth Conference?
The Emerging Growth Conference offers a critical platform for public companies to present their products, services, and key announcements to the investment community. It provides an efficient way for companies to connect with potential investors directly from their offices, simplifying the communication process.
Focusing on Growth Sectors
This conference highlights a range of growth sectors, shining a light on companies with strong management teams, innovative products, and a clear strategy for long-term growth. The audience is expected to include many individual and institutional investors, along with investment advisors and analysts.
About Regen BioPharma
Regen BioPharma, Inc. is a respected biotechnology firm (PINK: RGBP and PINK: RGBPP) dedicated to advancing the fields of immunology and immunotherapy. The company aims to rapidly advance its cutting-edge technologies through pre-clinical and Phase I/II clinical trials. With a focus on mRNA and small molecule therapies, Regen BioPharma is committed to addressing cancer and autoimmune disorders effectively.
Why Invest in Regen BioPharma?
Investors have the opportunity to delve into the exciting potential of Regen BioPharma's research and development initiatives, which reflect their dedication to significantly advancing healthcare solutions.
For further inquiries, please reach out using the contact details below:
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
Phone: +1-619-722-5505
Fax: +1-619-330-2328
Email: david.koos@regenbiopharma.com
Follow us on social media: X (formerly Twitter): https://x.com/TheRegenBio
Frequently Asked Questions
What is the Emerging Growth Conference?
The Emerging Growth Conference is a virtual space where companies can showcase their innovations and key announcements to investors.
How can I join the Regen BioPharma presentation?
Those interested should register ahead of time to participate and submit their questions during the live session.
What areas does Regen BioPharma focus on?
The company emphasizes immunology and immunotherapy, particularly in developing mRNA therapies aimed at treating cancer and autoimmune disorders.
Is a recording of the presentation available?
Yes, an archived version of the presentation will be accessible on EmergingGrowth.com for anyone unable to attend live.
Who can I contact at Regen BioPharma for more information?
If you have questions, you can contact David R. Koos via phone or email as provided in the article.